CW July 2004
Volume 13Issue Number 7 July 2004 ISSN 10593802 In CLL, Pretreating Bulky Lymph Nodes Increases ResponseInvestigators looking to increase remission rates for patients with chronic lymphocytic leukemia (CLL), found that patients with bulky lymph nodes, while least likely to respond to treatment, may respond better if they are pretreated with high dose methylprednisolone (HDMP) or CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) before consolidation with alemtuzumab (Campath, Berlex).
Go to Previous Page Go to Next Page Source & Additional Reading Peter Hillmen, MBChB, PhD, Haematological Malignancy Diagnostic Service, Leeds, UK, in a 40th Annual Meeting of the American Society of Clinical Oncology presentation. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
